KINECT-HD2 (HD3006): Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated with Huntington Disease02/19/2021 - 02/18/2024 (PI)
Neurocrine Biosciences
Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's…08/01/2020 - 01/31/2024 (Subcontract PI)
PI:
Stephanie Bissonnette, DOThe General Hospital Corporation / MGH Michael J. Fox Fdn
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety…01/22/2020 - 09/30/2023 (PI)
Neurocrine Biosciences